Home
Online Advanced Release
Current Issue
Online-only Articles
Back Issues
Product News
About the Journal
Advertising Info
Contact Us
Article Reprints
Article Submission
Buy a Book
Terms and Conditions
Careers at SLACK Inc.
ISIE
 
  e-contents - sign up today
  Subscribe to this Journal
Get daily Ophthalmic news at the OSN SuperSite

Schuman, Everyday OCT

Clinical Science

Anatomic and Visual Outcomes of Vitrectomy for Vitreomacular Traction Syndrome

Ophthalmic Surgery, Lasers and Imaging   Vol. 41   No. 4   July/August 2010
See the Full text
Andre J. Witkin, MD; Mark E. Patron, MD; Leonardo C. Castro, MD; Elias Reichel, MD; Adam H. Rogers, MD; Caroline R. Baumal, MD and Jay S. Duker, MD

Share/Save/Bookmark

 

BACKGROUND AND OBJECTIVE

To assess anatomic and visual outcomes after pars plana vitrectomy for vitreomacular traction syndrome.

PATIENTS AND METHODS

Charts of 746 patients who had vitrectomy surgery with membrane peel between January 2002 and December 2007 were reviewed. Vitreomacular traction syndrome (VMT) was diagnosed based on optical coherence tomography (OCT) appearance. Twenty eyes of 20 patients were found to have had vitrectomy surgery for VMT and were included in the study.

RESULTS

Mean visual acuity was 20/122 preoperatively and 20/68 postoperatively (P = .005). Mean foveal thickness was 404.00 µm preoperatively and 250.55 µm postoperatively (P = .001). A subgroup analysis was performed based on preoperative OCT appearance. Improvement in vision was not significant in eyes with lamellar separation between the inner and outer fovea (P = .379), but was significant in eyes with cystoid macular edema (P = .045) or perifoveal traction (P = .040).

CONCLUSION

Overall, there was a significant improvement in visual acuity and central foveal thickness postoperatively. Eyes with lamellar separation of the inner and outer foveal layers preoperatively had worse visual results, whereas eyes with cystoid macular edema or perifoveal VMT had better visual results.

[Ophthalmic Surg Lasers Imaging 2010;41:425-431.]

AUTHORS

From the Department of Ophthalmology, Tufts Medical Center, Boston, Massachusetts.

Originally submitted August 23, 2009. Accepted for publication January 28, 2010. Posted online May 28, 2010.

Presented at the Association for Research in Vision and Ophthalmology annual meeting, May 3 to 7, 2009, Fort Lauderdale, Florida.

Supported in part by an RPB Challenge grant to the New England Eye Center/Department of Ophthalmology, Tufts University School of Medicine and in part by a departmental grant from Massachusetts Lions.

Dr. Duker is a consultant for Alcon, Genentech, and Ophthotech, is a scientific advisor for Paloma Pharmaceuticals, and receives research support from Optivue and Carl Zeiss Meditec. The remaining authors have no financial or proprietary interest in the materials presented herein.

Dr. Duker did not participate in the editorial review of this manuscript.

Address correspondence to Andre J. Witkin, MD, Tufts Medical Center, 800 Washington Street, Box 450, Boston, MA 02111.

doi: 10.3928/15428877-20100525-07

See the Full text